Pharma Focus Asia
KP - Sustainable Packaging Solutions

Sanofi to Build a New World Class Research Centre


Sanofi plans to build a world class vaccine production site and a new research centre dedicated for the development of vaccines with an investment of €610 million.


Evolutive Vaccine Facility (EVF), the plant in Neuville sur Saône, will make use of the latest advanced vaccine production technologies. The new facility with an investment of €490 will allow securing vaccine supplies in case of pandemic outbreaks. In addition, another €120 million is invested to design a new R&D centre.

The new facility consists of a central unit for housing various fully digital production modules that facilitate production of three to four vaccines simultaneously. In addition, it consists of specialised laboratories for development of vaccines against emerging diseases and pandemic risks,thus becoming a world reference for pre-clinical research and, pharmaceutical and clinical development.

The facility will create 200 new job opportunities while the new production line will strengthen Sanofi’s capacity to invent new vaccines there by meeting public health issues.


Budget€610 million
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?